Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ZnAl-BrO3-LDHs catalyzed bromination method offers high selectivity and eco-friendly processing for reliable pharmaceutical intermediate supply chains.
Patent CN116903518A reveals efficient Pd-catalyzed route for OLED materials. Reduces cost and simplifies supply chain for electronic chemical manufacturing globally.
Novel organophosphine catalyzed method for diaryl methyl sulfide derivatives. High yield, mild conditions, scalable for pharma intermediates.
Patent CN104826634B reveals a stable catalyst for polyfluoro benzyl alcohol synthesis. This method ensures high yield and continuous production for reliable agrochemical intermediate supply chains.
Novel Mo-Ni/SiO2 catalyst enables high-yield synthesis of O-methyl caprolactam imide. Reduces waste and enhances supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114277023A details a novel biocatalytic route using recombinant E. coli and ion exchange resin for >99.99% purity nicotinamide.
Patent CN116323522B reveals a base-free ruthenium catalyst enabling stable, scalable production of optically active secondary alcohols with superior cost efficiency.
Patent CN102753537B details a safer Rivaroxaban synthesis route avoiding hydrobromic acid, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN106565620A reveals a novel gamma-Fe2O3 catalyst for tetrazole synthesis, offering high purity, cost reduction, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN102174006A details a novel chiral hydroxyl amide synthesis using copper acetate, offering high conversion rates for pharmaceutical intermediate manufacturing.
Patent CN104974088B reveals WO3/TiO2 catalyzed oxidation. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN102199103A details an improved oxidative coupling method for L-thyroxine sodium, enhancing yield and purity while reducing manufacturing costs for API intermediates.
Novel cobalt-catalyzed synthesis of Paxlovid key intermediate offers safer, shorter routes with reduced waste for reliable pharmaceutical intermediate supply chains.
Patent CN114644587A details a novel 3-step synthesis for Paxlovid's bicyclic imine intermediate, offering safer processing and cost reduction in API manufacturing.
Patent CN108264517A reveals novel herbicide intermediate route enabling cost reduction in agrochemical manufacturing and enhanced supply chain reliability for global buyers.
Patent CN112409125A reveals a continuous ionic liquid catalyzed route for diaryl hexafluoropropane, offering significant cost reduction and enhanced safety for advanced materials manufacturing.
Novel selenium-mediated cyclization for 2-benzoxazepines. High yield, mild conditions. Ideal for CNS drug intermediates. Cost-effective manufacturing solution.
Patent CN102586356B reveals an eco-friendly enzymatic route for quinoline heterocycles, offering high yields and reduced waste for pharmaceutical manufacturing.
Patent CN116103254B reveals stable enzyme mutants for UDCA. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112299962A reveals a novel supported chiral phosphoric acid catalyst for high-yield citral intermediate production, offering significant cost reduction and equipment longevity.